RecruitingNCT05962216
This observational study is following people with Psychosis or Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Dr. Albert Kar-Kin Chung
- Condition
- Depression
RecruitingNCT06376734
This study is looking at care and outcomes for people with depression, anxiety, or psychosis. Taking part may give some people access to Transcranial magnetic stimulation, but direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Brigham and Women's Hospital
- Condition
- Depression
RecruitingNCT06005766
This study is looking at whether a digital support tool can help people with depression or psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Finland
- Sponsor
- University of Jyvaskyla
- Condition
- Schizophrenia
RecruitingNCT06384209
This study is looking at whether Fluoxetine can help people with depression or Severe Depressive Episode Without Psychotic Symptoms. Participants receive Fluoxetine or usual care and complete study visits and assessments.
DepressionOtherOver 18 Years
- Countries
- Zimbabwe
- Sponsor
- University of Bern
- Condition
- Depression
Active Not RecruitingNCT04916626
This study is looking at whether cognitive behavioural therapy can help people with depression or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 12 Years to 17 Years
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Condition
- Schizophrenia
Not Yet RecruitingNCT06515522
This observational study is following people with Schizophrenia, bipolarity, or depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- IRCCS San Raffaele
- Condition
- Schizophrenia
RecruitingNCT07038876
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- MapLight Therapeutics
- Condition
- Schizophrenia
Active Not RecruitingNCT05905003
This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 12 Years to 30 Years
- Countries
- Australia, Canada, Chile, China, Denmark, Germany, Italy, Singapore, South Korea, Spain, Switzerland, United Kingdom, United States
- Sponsor
- Brigham and Women's Hospital
- Condition
- Schizophrenia
RecruitingNCT06562608
This study is comparing Anticholinergic Deprescription with Healthy Controls for people with Schizophrenia or schizoaffective disorder. Participants receive Anticholinergic Deprescription or Healthy Controls and complete study visits and assessments.
SchizophreniaOtherFrom 40 Years to 70 Years
- Countries
- United States
- Sponsor
- Deepak K. Sarpal, M.D.
- Condition
- Schizophrenia
RecruitingNCT05982158
This study is looking at whether cognitive behavioural therapy can help people with Auditory Hallucination, psychosis, or Schizophrenia and Related Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Australia
- Sponsor
- Swinburne University of Technology
- Condition
- Schizophrenia
RecruitingNCT03794076
This study is comparing Cromoglycate with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Cromoglycate or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vishwajit Nimgaonkar, MD PhD
- Condition
- Schizophrenia
Active Not RecruitingNCT06474195
This study is looking at whether questionnaires and follow-up can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- India
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
RecruitingNCT06745479
This observational study is following people with Schizophrenia, schizoaffective disorder, or Control Subjects to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Rutgers, The State University of New Jersey
- Condition
- Schizophrenia
RecruitingNCT06257056
This study is looking at demonstrate safety of acute and chronic network guided stimulation for treatment-refractory schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 22 Years to 70 Years
- Countries
- United States
- Sponsor
- Bradley Lega
- Condition
- Schizophrenia
RecruitingNCT05025605
This study is comparing BXCL501 80 Micrograms with placebo for people with psychosis or bipolarity. Participants receive BXCL501 80 Micrograms or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Schizophrenia
Active Not RecruitingNCT03788811
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Canada, United States
- Sponsor
- diaMentis Inc.
- Condition
- Schizophrenia
RecruitingNCT06197048
This study is looking at whether Nutritional counseling can help people with Cardiovascular Diseases, Schizophrenia, Psychosis, or bipolarity. Participants take part in Nutritional counseling and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Norway
- Sponsor
- Vestre Viken Hospital Trust
- Condition
- Schizophrenia
RecruitingNCT05805397
This study is looking at take place at four outpatient clinics serving adults with serious mental illness for people with Schizophrenia or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Schizophrenia
RecruitingNCT04267003
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Sham Stimulation + Task instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 47 Years
- Countries
- United States
- Sponsor
- University of California, Davis
- Condition
- Schizophrenia
Not Yet RecruitingNCT06474325
This study is looking at whether psychoeducation can help people with Schizophrenia or Schizo Affective Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- India
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
RecruitingNCT05890183
This study is looking at whether a digital support tool can help people with Schizophrenia, Schizophreniform Disorder, or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
RecruitingNCT06301347
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Pakistan
- Sponsor
- Pakistan Institute of Living and Learning
- Condition
- Schizophrenia
RecruitingNCT06174116
This study is comparing Lumateperone with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Lumateperone or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Massachusetts, Worcester
- Condition
- Schizophrenia
RecruitingNCT07469384
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1 or Schizo Affective Disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Condition
- Schizophrenia
RecruitingNCT05956951
This study is looking at whether Closed-loop auditory stimulation can help people with Schizophrenia. Participants take part in Closed-loop auditory stimulation and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Fabio Ferrarelli
- Condition
- Schizophrenia